China Shineway Pharmaceutical Group Limited (HKG:2877)

Market Cap	7.81B +22.1%
Revenue (ttm)	3.49B -17.0%
Net Income	1.06B +13.1%
EPS	1.40 +13.1%
Shares Out	755.40M
PE Ratio	7.39
Forward PE	7.12
Dividend	0.54 (5.46%)
Ex-Dividend Date	May 4, 2026

Volume	661,000
Average Volume	1,692,079
Open	10.34
Previous Close	10.34
Day's Range	10.12 - 10.34
52-Week Range	6.96 - 10.47
Beta	0.84
RSI	63.40
Earnings Date	Mar 27, 2026

About HKG:2877

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; tablets, pills, oral liquid, and powder; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovascular, ortho...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2002
• Employees: 2,867
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2877

Financial Performance

In 2025, HKG:2877's revenue was 3.14 billion, a decrease of -17.01% compared to the previous year's 3.78 billion. Earnings were 949.95 million, an increase of 13.08%.

Financial numbers in CNY